0.7246

2.08% -0.0154

Dare Bioscience Inc (DARE)

Overview News Price History Financials Discussions Forecast Stock Split

Dare Bioscience Inc stock is traded at $0.7246, with a volume of 77,208. It is down -2.08% in the last 24 hours and down -0.12% over the past month. Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Previous Close:

$0.74

Open:

$0.7392

24h Volume:

77,208

Relative Volume:

0.75

Market Cap:

$14.25M

Revenue:

$1.16M

Net Income/Loss:

$-12.02M

P/E Ratio:

-0.698

EPS:

-1.0381

Net Cash Flow:

$-10.16M

1W Performance:

-6.31%

1M Performance:

-0.12%

6M Performance:

-73.36%

1Y Performance:

-65.82%

1-Day Range:

$0.7126

$0.7397

1-Week Range:

$0.7126

$0.7901

52-Week Range:

$0.69

$3.78

Dare Bioscience Inc Stock (DARE) Company Profile

Name

Dare Bioscience Inc

Sector

Healthcare (1052)

Industry

Biotechnology (594)

Phone

858-926-7655

Address

3655 NOBEL DRIVE, SAN DIEGO, CA

Employee

Twitter

@DareBioscience

Next Earnings Date

2026-11-12

Latest SEC Filings

DARE's Discussions on Twitter

Compare DARE vs VRTX, MRNA, REGN, ARGX, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DARE Dare Bioscience Inc	0.7246	14.25M	1.16M	-12.02M	-10.16M	-1.0381
VRTX Vertex Pharmaceuticals Inc	499.74	126.66B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	218.01	87.04B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	790.74	81.41B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	819.14	51.51B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	369.06	41.75B	5.76B	514.49M	1.10B	4.4813

Dare Bioscience Inc Stock (DARE) Latest News

Oct 08, 2026

Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting - The Manila Times

Oct 08, 2026

Daré Bioscience Announces Phase 1 Sildenafil Cream Data to Be Presented at SMSNA Annual Fall Scientific Meeting - Quiver Quantitative

Oct 08, 2026

Oct 02, 2026

Daré Bioscience Faces Nasdaq Minimum Bid Price Noncompliance - TipRanks

Oct 02, 2026

Daré Bioscience Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Oct 02, 2026

Sep 28, 2026

Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection - manilatimes.net

Sep 28, 2026

Sep 23, 2026

Warrants covering about 45% of existing shares await a vote at Daré Bioscience (NASDAQ: DARE). - Stock Titan

Sep 23, 2026

Sep 14, 2026

Daré Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil - manilatimes.net

Sep 14, 2026

Sep 12, 2026

Form 8K Dare Bioscience Inc For: 11 September By Investing.com - Investing.com Australia

Sep 12, 2026

Dare Bioscience amends bylaws to lower quorum for shareholder meetings By Investing.com - Investing.com Australia

Sep 12, 2026

Sep 11, 2026

Form 8K Dare Bioscience Inc For: 11 September By Investing.com - Investing.com Nigeria

Sep 11, 2026

Form 8K Dare Bioscience Inc For: 11 September By Investing.com - Investing.com South Africa

Sep 11, 2026

Dare Bioscience amends bylaws to lower quorum for shareholder meetings By Investing.com - Investing.com Canada

Sep 11, 2026

Dare Bioscience amends bylaws to lower quorum for shareholder meetings - Investing.com

Sep 11, 2026

Form 8K Dare Bioscience Inc For: 11 September By Investing.com - Investing.com India

Sep 11, 2026

Daré Bioscience at H.C. Wainwright conference: turning to sales By Investing.com - Investing.com Canada

Sep 11, 2026

Daré Bioscience at H.C. Wainwright conference: turning to sales By Investing.com - Investing.com Nigeria

Sep 11, 2026

Daré Bioscience at H.C. Wainwright conference: turning to sales - Investing.com

Sep 11, 2026

Daré Bioscience at H.C. Wainwright conference: turning to sales By Investing.com - Investing.com India

Sep 11, 2026

Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand - The Manila Times

Sep 11, 2026

Daré Bioscience Presentation for H.C. Wainwright 28th - GlobeNewswire

Sep 11, 2026

Dare Bioscience amends bylaws to lower quorum for shareholder meetings By Investing.com - Investing.com South Africa

Sep 11, 2026

Dare Bioscience amends bylaws to lower quorum for shareholder meetings - Investing.com

Sep 11, 2026

Sep 08, 2026

Dare Bioscience (NASDAQ: DARE) Eyes Up to $12.4M from Warrants to Boost 503B and Consumer Health Initiatives - kalkinemedia.com

Sep 08, 2026

Patient data from an Alzheimer’s drug is anticipated by late 2027 or early 2028 - Stock Titan

Sep 08, 2026

Sep 04, 2026

Dare Bioscience, Inc. SEC Filing (Sep 4, 2026) - Stock Titan

Sep 04, 2026

Sep 03, 2026